Hca Healthcare Inc - HCA STOCK NEWS

HCA Healthcare (NYSE: HCA) announced that its subsidiary, HCA Inc., plans to offer senior notes, with terms including maturity, interest rate, and principal amount to be determined based on market conditions. The net proceeds will be used for general corporate purposes, potentially including repayment of existing or future senior credit facilities.

The offering is being conducted through major financial institutions including BofA Securities, Barclays Capital, Citigroup Global Markets, J.P. Morgan Securities, Mizuho Securities USA, and Wells Fargo Securities as joint book-running managers. The offering is being made through an effective shelf registration statement filed with the SEC, available via prospectus from the managing institutions.

HCA Healthcare announced that 49 of its hospitals have been named on the 2025 Healthgrades America's 250 Best Hospitals list, representing the top 5% of hospitals nationwide for clinical excellence. The recognition is based solely on patient outcomes across multiple specialty areas.

To qualify, hospitals needed evaluations in at least 21 of 31 Healthgrades procedures and conditions, using Medicare inpatient data. The assessment involved analyzing risk-adjusted mortality and complication rates across approximately 4,500 hospitals nationwide.

Mission Hospital in Asheville, North Carolina achieved the prestigious America's 50 Best Hospitals Award, marking its 10th consecutive year of recognition. Additionally, ten HCA Healthcare facilities were named among America's 100 Best Hospitals, including facilities from HCA HealthONE, HCA Florida, and other notable institutions, placing them in the top 2% nationally for consistent clinical excellence.

HCA Healthcare reported strong Q4 2024 financial results with revenues of $18.285 billion, up from $17.303 billion in Q4 2023. Net income was $1.438 billion ($5.63 per diluted share), compared to $1.607 billion ($5.93 per diluted share) in Q4 2023, including a $0.60 per share impact from Hurricanes Helene and Milton.

Key operational metrics showed positive trends with same facility admissions increasing 3.0%, emergency room visits up 2.4%, and inpatient surgeries rising 2.8%. The company's full-year 2024 revenues reached $70.603 billion with net income of $5.760 billion.

Looking ahead, HCA provided 2025 guidance projecting revenues between $72.80-$75.80 billion, net income of $5.85-$6.29 billion, and EPS of $24.05-$25.85. The Board authorized a new $10 billion share repurchase program and declared a quarterly dividend of $0.72 per share.

HCA Healthcare (NYSE: HCA) has announced its upcoming fourth quarter 2024 earnings conference call, scheduled for Friday, January 24, 2025, at 9:00 AM Central Time (10:00 AM Eastern). The earnings call will be accessible via live audio webcast through the company's investor relations website.

Interested parties can join the webcast at https://investor.hcahealthcare.com/events-and-presentations/default.aspx. For those unable to attend the live session, an archived version will be available at the same web address. Frank Morgan, Vice President of Investor Relations, is available for investor-related inquiries.

HCA Healthcare (NYSE:HCA) has appointed Wendy Warren as senior vice president and chief ethics and compliance officer, effective March 3, 2025. Warren, a 10-year veteran of HCA Healthcare, will succeed Kathi Whalen, who is retiring after 27 years with the company. Warren will lead the company's ethics, compliance and regulatory department, previously serving as associate general counsel and vice president of payer contracting and alignment at Parallon. Whalen, who joined in 1998, helped develop the company's code of conduct, policies, procedures, and annual training programs, while also serving as chair of HCA Healthcare's Sustainability Steering Committee.

HCA Healthcare announced record-breaking results from its sixth annual 'Crush the Crisis' prescription drug take-back day, collecting 21,137 pounds of unused or expired medications. This represents approximately 14.5 million doses collected across more than 125 collection sites. The initiative, conducted in partnership with local law enforcement and aligned with the DEA's National Prescription Drug Take Back Day, has now collected over 88,600 pounds of medication since 2019. Top collecting facilities included CJW Medical Center in Virginia (992 pounds) and HCA HealthONE Aurora in Colorado (861 pounds).

The Frist Foundation has donated $1 million to the HCA Healthcare Hope Fund to support employees affected by Hurricanes Helene and Milton. The devastating hurricanes left over four million people without power in the Southeast region. More than 3,400 HCA Healthcare colleagues have received assistance, with $2.7 million in grants already distributed to those impacted. The HCA Healthcare Hope Fund, a 501(c)(3) charity, has provided over $113 million through more than 60,000 grants since its inception to help employees and their immediate families facing financial hardship.

HCA Healthcare has been named a Best for Vets Employer by Military Times for the fifth consecutive year, recognizing its commitment to recruiting and supporting veterans. The company has hired over 65,000 veterans, active-duty personnel, and military spouses since 2012. In honor of Veterans Day, HCA Healthcare is donating $150,000 to support various veteran-focused organizations including Armed Services YMCA, CreatiVets, The Honor Foundation, and Operation Stand Down.

The company has earned multiple recognitions, including the Gold distinction from VIQTORY for the second year running. HCA Healthcare maintains a Veterans Colleague Network and offers military leave with supplemental pay to eligible employees serving on active duty.

HCA Healthcare reported strong Q3 2024 financial results with revenues of $17.487 billion, up from $16.213 billion in Q3 2023. Net income reached $1.270 billion ($4.88 per diluted share), including a $0.15 per share impact from Hurricane Helene. Same facility admissions and equivalent admissions both increased 4.5%. Emergency room visits rose 4.6%, while inpatient surgeries grew 1.6%. The company maintained its 2024 guidance but expects results in the lower half of the range due to hurricane impacts, with anticipated Q4 hurricane-related costs of $200-300 million.